Insights

Innovative Genomics Solutions Intelliseq offers modular, automated bioinformatics pipelines that facilitate fast, scalable, and regulatory-ready NGS data analysis, making it an attractive partner for diagnostic labs and research institutions seeking streamlined genomics workflows.

Strategic Partnerships Recent collaborations with industry leaders like Sysmex and Oxford Gene Technology, as well as integration with GenomeWeb and Genomenon, demonstrate a strong position in building strategic alliances that enhance product capabilities and market reach.

Growing Market Presence With recent funding of approximately $4.9 million and a proven track record of product launches such as GeneSpect Somatic Reporter, Intelliseq is expanding its footprint within the biotech and clinical research sectors, offering growth opportunities for sales engagements.

Technology Adoption Utilizing a range of tech stack components including cloud-based platforms and automated workflows, Intelliseq emphasizes ease of use and regulatory compliance, appealing to organizations looking for cutting-edge, user-friendly genomic data analysis solutions.

Market Niche Focus Specializing in clinical and research genomics with a focus on precision medicine, Intelliseq's tailored solutions present a targeted opportunity to engage healthcare providers, diagnostic companies, and biopharma firms seeking innovative genomic analysis tools.

Similar companies to Intelliseq

Intelliseq Tech Stack

Intelliseq uses 8 technology products and services including Linkedin Insight Tag, Fullstory, Unpkg, and more. Explore Intelliseq's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • Fullstory
    Analytics
  • Unpkg
    Content Delivery Network
  • Open Graph
    Content Management System
  • WordPress
    Content Management System
  • Bunny Fonts
    Font Scripts
  • Google Fonts API
    Font Scripts
  • Exhibit
    Javascript Graphics

Media & News

Intelliseq's Email Address Formats

Intelliseq uses at least 2 format(s):
Intelliseq Email FormatsExamplePercentage
First.Last@intelliseq.plJohn.Doe@intelliseq.pl
80%
First@intelliseq.plJohn@intelliseq.pl
10%
Last@intelliseq.plDoe@intelliseq.pl
10%

Frequently Asked Questions

What is Intelliseq's official website and social media links?

Minus sign iconPlus sign icon
Intelliseq's official website is intelliseq.com and has social profiles on LinkedInCrunchbase.

What is Intelliseq's SIC code NAICS code?

Minus sign iconPlus sign icon
Intelliseq's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Intelliseq have currently?

Minus sign iconPlus sign icon
As of December 2025, Intelliseq has approximately 16 employees across 2 continents, including North AmericaEurope. Key team members include Ceo, Co-Founder: K. S.Chief Technology Officer & Co-Founder: M. P.Chief Commercial Officer (cco): D. H.. Explore Intelliseq's employee directory with LeadIQ.

What industry does Intelliseq belong to?

Minus sign iconPlus sign icon
Intelliseq operates in the Biotechnology Research industry.

What technology does Intelliseq use?

Minus sign iconPlus sign icon
Intelliseq's tech stack includes Linkedin Insight TagFullstoryUnpkgOpen GraphWordPressBunny FontsGoogle Fonts APIExhibit.

What is Intelliseq's email format?

Minus sign iconPlus sign icon
Intelliseq's email format typically follows the pattern of First.Last@intelliseq.pl. Find more Intelliseq email formats with LeadIQ.

How much funding has Intelliseq raised to date?

Minus sign iconPlus sign icon
As of December 2025, Intelliseq has raised $4.9M in funding. The last funding round occurred on Mar 28, 2025 for $4.9M.

When was Intelliseq founded?

Minus sign iconPlus sign icon
Intelliseq was founded in 2013.

Intelliseq

Biotechnology ResearchLesser Poland, Poland11-50 Employees

Intelliseq is a genomics company turning complex DNA data into clear, actionable insights. Our bespoke pipelines allow for modular bioinformatics workflows to make next-generation sequencing (NGS) interpretation fast, scalable, and clinically relevant - empowering diagnostic labs, biopharma, and research institutions to accelerate precision medicine. By delivering user-friendly, automated pipelines that ensure reproducibility and regulatory readiness, Intelliseq bridges the gap between complex genomics and practical healthcare solutions - without the need for in-house bioinformatics expertise.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $4.9M

    Intelliseq has raised a total of $4.9M of funding over 4 rounds. Their latest funding round was raised on Mar 28, 2025 in the amount of $4.9M.

  • $1M$10M

    Intelliseq's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $4.9M

    Intelliseq has raised a total of $4.9M of funding over 4 rounds. Their latest funding round was raised on Mar 28, 2025 in the amount of $4.9M.

  • $1M$10M

    Intelliseq's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.